BONE AND JOINT INFECTIONS CAUSED BY MULTIPLY RESISTANT STAPHYLOCOCCUS-AUREUS IN A NEONATAL INTENSIVE-CARE UNIT

被引:33
作者
ISHHOROWICZ, MR
MCINTYRE, P
NADE, S
机构
[1] WESTMEAD HOSP,DEPT PAEDIAT,WESTMEAD,NSW 2145,AUSTRALIA
[2] WESTMEAD HOSP,DEPT PERINATAL MED,WESTMEAD,NSW 2145,AUSTRALIA
[3] WESTMEAD HOSP,DEPT SURG,WESTMEAD,NSW 2145,AUSTRALIA
关键词
JOINT INFECTIONS; BONE INFECTIONS; NEONATAL; STAPHYLOCOCCUS-AUREUS;
D O I
10.1097/00006454-199202000-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Twenty cases of osteomyelitis and/or septic arthritis caused by multiply resistant Staphylococcus aureus were documented in an Australian tertiary neonatal unit between 1981 and 1987. Eighteen (90%) occurred in the 3 years 1985 to 1987, an incidence of 9.6/1000 admissions in that period. All osteomyelitis and/or septic arthritis occurred in sick premature infants requiring intensive support. Eleven (55%) had a birth weight of less than 1500 g. An intravascular device was the most common portal of entry (14 of 20, 70%). Systemic symptoms were prominent at presentation, with local signs developing later in 18 (90%), usually within a week. Radiologic changes were almost always present by 10 days; radionuclide bone scanning was insensitive and did not hasten diagnosis. Osteomyelitis was multifocal in 11 cases (55%), with the long bones, particularly of the upper limb, most commonly affected. Large joint involvement was uncommon (15%). Intravenous vancomycin for a mean of 32 days was associated with low mortality (1 of 20) and toxicity; surgical drainage was not performed. Follow-up at a minimum of 4 months (mean, 25.5 months) showed residual signs in the affected limb in 30%, none with significantly impaired function. Skeletal infection should be searched for rigorously in neonatal multiply resistant S. aureus sepsis. In the absence of large joint disease, vancomycin therapy alone for a minimum of 3 weeks gives good short term results with minimal toxicity.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 37 条
[11]   EPIDEMIC NEONATAL GENTAMICIN-METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTION ASSOCIATED WITH NONSPECIFIC TOPICAL USE OF GENTAMICIN [J].
GRAHAM, DR ;
CORREAVILLASENOR, A ;
ANDERSON, RL ;
VOLLMAN, JH ;
BAINE, WB .
JOURNAL OF PEDIATRICS, 1980, 97 (06) :972-978
[12]   VANCOMYCIN CONCENTRATIONS IN INFECTED AND NONINFECTED HUMAN-BONE [J].
GRAZIANI, AL ;
LAWSON, LA ;
GIBSON, GA ;
STEINBERG, MA ;
MACGREGOR, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) :1320-1322
[13]  
Ho N K, 1989, Singapore Med J, V30, P356
[14]   VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS [J].
JAMES, A ;
KOREN, G ;
MILLIKEN, J ;
SOLDIN, S ;
PROBER, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :52-54
[15]   CHANGING STAPHYLOCOCCI AND STAPHYLOCOCCAL INFECTIONS - A 10-YEAR STUDY OF BACTERIA AND CASES OF BACTEREMIA [J].
JESSEN, O ;
ROSENDAL, K ;
BULOW, P ;
FABER, V ;
ERIKSEN, KR .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (12) :627-&
[17]   ANTIBIOTIC-RESISTANT STAPHYLOCOCCI IN A TEACHING HOSPITAL [J].
KING, K ;
BRADY, L ;
THOMSON, M ;
HARKNESS, JL .
MEDICAL JOURNAL OF AUSTRALIA, 1982, 2 (10) :461-465
[18]   CLINICAL, EPIDEMIOLOGIC AND BACTERIOLOGIC OBSERVATIONS OF AN OUTBREAK OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AT A LARGE COMMUNITY-HOSPITAL [J].
KLIMEK, JJ ;
MARSIK, FJ ;
BARTLETT, RC ;
WEIR, B ;
SHEA, P ;
QUINTILIANI, R .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (03) :340-345
[19]  
KLINE MW, 1988, PEDIATR CLIN N AM, V35, P613
[20]   NEONATAL OSTEOMYELITIS [J].
KNUDSEN, CJM ;
HOFFMAN, EB .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1990, 72 (05) :846-851